Delving into the Latest Updates on Zhejiang Kangle Pharmaceutical Co., Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

ADA(Adenosine deaminase)	1

主要研究目的：研究空腹/餐后状态下，单次口服厄多司坦胶囊受试制剂（和坦®，规格：0.3g ，浙江康乐药业股份有限公司）与参比制剂（ERDOTIN®，规格：0.3g，Edmond Pharma S.r.l.）在健康受试者体内的药代动力学行为，评价空腹/餐后状态下口服两种制剂的生物等效性。

[Translation]

The main purpose of the study is to study the pharmacokinetic behavior of the test formulation of erdosteine capsules (Hetan®, specification: 0.3g, Zhejiang Kangle Pharmaceutical Co., Ltd.) and the reference formulation (ERDOTIN®, specification: 0.3g, Edmond Pharma S.r.l.) in healthy subjects after a single oral administration under fasting/fed conditions, and to evaluate the bioequivalence of the two oral formulations under fasting/fed conditions.

Start Date10 Feb 2022

Sponsor / Collaborator

Zhejiang Kangle Pharmaceutical Co., Ltd.

100 Clinical Results associated with Zhejiang Kangle Pharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Zhejiang Kangle Pharmaceutical Co., Ltd.

Login to view more data

2

Literatures (Medical) associated with Zhejiang Kangle Pharmaceutical Co., Ltd.

Zhongguo Yiyao Gongye Zazhi

Synthesis of cefpodoxime proxetil

Author: Chen, Jingwei ; Yao, Yuanhai ; Liu, Aimin

The compound 1-iodoethyl iso-Pr carbonate (2), prepared from 1-chloroethyl chloroformate in 43.7% yield was used to prepare cefpodoxime proxetil by esterification with cefpodoxime in 70% yield.

Linchan Huaxue Yu Gongye

Current situation of natural plant pharmaceuticals market and countermeasures

Author: Yu, Yong-hua

With the trend of returning to nature,natural plant pharmaceuticals have become one of the important part of medicinal marked in the world.China has the most abundant natural pharmaceutical resources in the world,and has an unique theory system of Chinese traditional medicine.But our R & D of natural plant pharmaceuticals lag behind obviously.This article briefly reviews the current situation of natural plant pharmaceuticals market and explores the countermeasures to accelerate the development of our natural plant pharmaceuticals.

100 Deals associated with Zhejiang Kangle Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Zhejiang Kangle Pharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 15 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Other

Login to view more data